98977-34-5 Usage
Description
N-Boc-3-carboethoxy-4-piperidone, also known as Boc-piperidone, is a chemical compound with the molecular formula C13H21NO4. It is a white to off-white crystalline powder that is commonly used as a building block in organic synthesis, particularly in the pharmaceutical industry. It is typically used as a key intermediate in the production of various drugs and pharmaceutical products. N-Boc-3-carboethoxy-4-piperidone is known for its potential to act as a precursor in the synthesis of a variety of bioactive molecules. Its versatile nature and reactivity make it an important tool for chemists in the development of new drug candidates and therapeutic agents.
Uses
Used in Pharmaceutical Industry:
N-Boc-3-carboethoxy-4-piperidone is used as a key intermediate for the synthesis of various drugs and pharmaceutical products. Its versatile nature and reactivity make it an important tool for chemists in the development of new drug candidates and therapeutic agents.
Used in Organic Synthesis:
N-Boc-3-carboethoxy-4-piperidone is used as a building block in organic synthesis, particularly in the pharmaceutical industry. It serves as a precursor in the synthesis of a variety of bioactive molecules, contributing to the discovery and development of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 98977-34-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,8,9,7 and 7 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 98977-34:
(7*9)+(6*8)+(5*9)+(4*7)+(3*7)+(2*3)+(1*4)=215
215 % 10 = 5
So 98977-34-5 is a valid CAS Registry Number.
InChI:InChI=1/C13H21NO5/c1-5-18-11(16)9-8-14(7-6-10(9)15)12(17)19-13(2,3)4/h9H,5-8H2,1-4H3
98977-34-5Relevant articles and documents
PYRIMIDINE-BASED BICYCLES AS ANTIVIRAL AGENTS FOR THE TREATMENT AND PREVENTION OF HIV INFECTION
-
Page/Page column 74-77; 99-100; 114; 116; 118-121; 123-124; ..., (2021/08/27)
This invention relates to pyrimidine derivatives, having HIV replication inhibiting. The present invention provides new pyrimidine compounds, designed for the treatment and prevention of HIV-mediated diseases. The invention further relates to pharmaceutical compositions and drugs contained in them. The invention also relates to the use of abovementioned compounds for the treatment and/or prevention of HIV in subjects with HIV-infection (human immunodeficiency virus) or having risk of getting HIV-infection.